These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways. Halls ML; van der Westhuizen ET; Bathgate RA; Summers RJ Br J Pharmacol; 2007 Mar; 150(6):677-91. PubMed ID: 17293890 [TBL] [Abstract][Full Text] [Related]
29. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3). van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943 [TBL] [Abstract][Full Text] [Related]
30. Relaxin family peptides and their receptors. Bathgate RA; Halls ML; van der Westhuizen ET; Callander GE; Kocan M; Summers RJ Physiol Rev; 2013 Jan; 93(1):405-80. PubMed ID: 23303914 [TBL] [Abstract][Full Text] [Related]
31. Roles of the receptor, the ligand, and the cell in the signal transduction pathways utilized by the relaxin family peptide receptors 1-3. Summers RJ; Bathgate RA; Wade JD; van der Westhuizen ET; Halls ML Ann N Y Acad Sci; 2009 Apr; 1160():99-104. PubMed ID: 19416167 [TBL] [Abstract][Full Text] [Related]
32. Distribution of relaxin-3 and RXFP3 within arousal, stress, affective, and cognitive circuits of mouse brain. Smith CM; Shen PJ; Banerjee A; Bonaventure P; Ma S; Bathgate RA; Sutton SW; Gundlach AL J Comp Neurol; 2010 Oct; 518(19):4016-45. PubMed ID: 20737598 [TBL] [Abstract][Full Text] [Related]
33. The electrostatic interactions of relaxin-3 with receptor RXFP4 and the influence of its B-chain C-terminal conformation. Wang XY; Guo YQ; Zhang WJ; Shao XX; Liu YL; Xu ZG; Guo ZY FEBS J; 2014 Jul; 281(13):2927-36. PubMed ID: 24802387 [TBL] [Abstract][Full Text] [Related]
34. Modulation of feeding by chronic rAAV expression of a relaxin-3 peptide agonist in rat hypothalamus. Ganella DE; Callander GE; Ma S; Bye CR; Gundlach AL; Bathgate RA Gene Ther; 2013 Jul; 20(7):703-16. PubMed ID: 23135160 [TBL] [Abstract][Full Text] [Related]
35. Development of a synthetic relaxin-3/INSL5 chimeric peptide ligand for NanoBiT complementation binding assays. Wu H; Hoare BL; Handley TNG; Akhter Hossain M; Bathgate RAD Biochem Pharmacol; 2024 Jun; 224():116238. PubMed ID: 38677442 [TBL] [Abstract][Full Text] [Related]
36. Modeling the primary hormone-binding site of RXFP1 and RXFP2. Scott DJ; Tregear GW; Bathgate RA Ann N Y Acad Sci; 2009 Apr; 1160():74-7. PubMed ID: 19416162 [TBL] [Abstract][Full Text] [Related]
37. Hydrophobic interactions of relaxin family peptide receptor 3 with ligands identified using a NanoBiT-based binding assay. Li HZ; Li N; Shao XX; Liu YL; Xu ZG; Guo ZY Biochimie; 2020 Oct; 177():117-126. PubMed ID: 32810565 [TBL] [Abstract][Full Text] [Related]
38. Exploring electrostatic interactions of relaxin family peptide receptor 3 and 4 with ligands using a NanoBiT-based binding assay. Wang JH; Nie WH; Shao XX; Li HZ; Hu MJ; Liu YL; Xu ZG; Guo ZY Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):776-786. PubMed ID: 30684458 [TBL] [Abstract][Full Text] [Related]
39. Relaxin-3/insulin-like peptide 5 chimeric peptide, a selective ligand for G protein-coupled receptor (GPCR)135 and GPCR142 over leucine-rich repeat-containing G protein-coupled receptor 7. Liu C; Chen J; Kuei C; Sutton S; Nepomuceno D; Bonaventure P; Lovenberg TW Mol Pharmacol; 2005 Jan; 67(1):231-40. PubMed ID: 15465925 [TBL] [Abstract][Full Text] [Related]
40. Structure of human insulin-like peptide 5 and characterization of conserved hydrogen bonds and electrostatic interactions within the relaxin framework. Haugaard-Jönsson LM; Hossain MA; Daly NL; Craik DJ; Wade JD; Rosengren KJ Biochem J; 2009 May; 419(3):619-27. PubMed ID: 19178384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]